Resources from the same session
238MO - Long-term residential and workplace exposure to air pollution and breast cancer risk: A case-control study nested in the French E3N cohort from 1990 to 2011
Presenter: Beatrice Fervers
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA22 - Connected device and therapeutic patient education to promote physical activity among in women with localized breast cancer: Results from the DISCO randomized trial
Presenter: Beatrice Fervers
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
239MO - Impact of body mass index and its change on survival outcomes in patients with early breast cancer: A pooled analysis of individual-level data from BCIRG-001 and BCIRG-005 trials
Presenter: Haizhu Chen
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Invited Discussant 238MO, LBA22 and 239MO
Presenter: Ines Vaz Luis
Session: Mini oral session - Breast cancer, early stage
Resources:
Slides
Webcast
240MO - Prognostic and predictive impact of estrogen/progesterone receptor (ER/PR), and Ki-67 expression: An exploratory analysis from the monarchE trial in patients with high-risk, HR+, HER2-, early breast cancer (EBC)
Presenter: Matthew Goetz
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA23 - Invasive disease–free survival (iDFS) across key subgroups from the phase III NATALEE study of ribociclib (RIB) + a nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2- early breast cancer (EBC)
Presenter: Aditya Bardia
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
241MO - Patient characteristics and real-world outcomes in HER2 negative/ ER zero and ER low patients treated as triple-negative breast cancer in Sweden 2008-2020
Presenter: Irma Fredriksson
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
242MO - Association of tumor-infiltrating lymphocytes (TILs) with recurrence score (RS) in patients with hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer (BC): A translational analysis of four prospective multicentric studies
Presenter: Federica Miglietta
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA24 - Multiparametric prognostic score in early HR+/HER2- breast cancer: Impact of recurrence score, clinical-pathological factors, gene mutations and histology
Presenter: Oleg Gluz
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
243MO - Omission of breast surgery after neoadjuvant systemic therapy for invasive cancer: Three-year preplanned primary-endpoint on a phase II multicentre prospective trial
Presenter: Henry M. Kuerer
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast